Beta-blockers: Off-label use in psychiatric disorders

William J. Newman, Glen Xiong, Amy V Barnhorst

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Psychiatrists have long prescribed beta-blockers in various clinical situations. Although many uses are well established in psychiatric practice, they are all offlabel indications. The term "off-label" refers to the use of an existing medication for purposes other than those specifically approved by the FDA. Off-label prescriptions are common throughout medicine and are entirely legal. They may, however, be viewed with additional scrutiny in the event of a lawsuit involving a negative treatment outcome.

Original languageEnglish (US)
Pages (from-to)73-80
Number of pages8
JournalPsychopharm Review
Issue number10
StatePublished - 2013

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)


Dive into the research topics of 'Beta-blockers: Off-label use in psychiatric disorders'. Together they form a unique fingerprint.

Cite this